OTC:ASLTY

AUM Biosciences and Asymchem Complete Phase II API Production Campaign of Novel TRK Inhibitor

TEDA TIANJIN, P.R. China and SINGAPORE, Oct. 20, 2022 /PRNewswire/ -- Asymchem (stock code: 002821.SZ), a leading global contract development and manufacturing service provider, and AUM Biosciences (AUM), a global clinical stage biotech company, focused on discovering, acquiring and developing ne...

2022-10-20 20:30 2251